Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.39
-0.09 (-1.39%)
Jul 21, 2026, 1:06 PM EDT - Market open
Abeona Therapeutics Employees
Abeona Therapeutics had 226 employees as of December 31, 2025. The number of employees increased by 90 or 66.18% compared to the previous year.
Employees
226
Change (1Y)
90
Growth (1Y)
66.18%
Revenue / Employee
$64,336
Profits / Employee
$292,642
Market Cap
364.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 226 | 90 | 66.18% |
| Dec 31, 2024 | 136 | 52 | 61.90% |
| Dec 31, 2023 | 84 | 27 | 47.37% |
| Dec 31, 2022 | 57 | -33 | -36.67% |
| Dec 31, 2021 | 90 | 14 | 18.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Rocket Pharmaceuticals | 202 |
| Sutro Biopharma | 133 |
| Enanta Pharmaceuticals | 120 |
| Zentalis Pharmaceuticals | 106 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 59 |
| Compass Therapeutics | 39 |
ABEO News
- 3 hours ago - Abeona Therapeutics activates Cincinnati Children’s as treatment center - TheFly
- 5 hours ago - Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN® - GlobeNewsWire
- 20 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Abeona Therapeutics Slides: Investor presentation - Filings
- 6 weeks ago - Abeona Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Abeona Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts